Pancreas Lipotoxicity in T2D: Edinburgh Diabetes Remission Study (EDRS) — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Pancreas Lipotoxicity in T2D: Edinburgh Diabetes Remission Study (EDRS) — Stella

Home/Type 2 Diabetes/

View on ClinicalTrials.gov

Recruiting

Back to Type 2 Diabetes trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United Kingdom

Clinical Research Facility, Royal Infirmary of Edinburgh, Edinburgh

Key details

Sponsor

University of Edinburgh

Collaborators

NHS Lothian

Enrollment target

~104 participants

Started

January 2026

Primary completion

March 2029

Age range

45 Years – 79 Years

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.